| Followers | 232 |
| Posts | 26887 |
| Boards Moderated | 0 |
| Alias Born | 01/12/2013 |
Saturday, July 02, 2016 10:40:40 AM
JL & FFS
You both clearly have a grasp of the situation, but the spike Feb 2015 supports FFS. A VW squeeze is possible.
BB
http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&s_symbol_select=NASDAQ%3AAMRN&ctl00%24sb3%24tbq1=&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=NASDAQ%3AAMRN&s_ok=Get+Chart&period=6&drawmode=2&size=18&volume=1
We could see a quick pop to $20 with spike in volume >10 million. For the chart to full correct we need 100 million shares traded day...like the post Oct 16th Ad Com.http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&s_symbol_select=NASDAQ%3AAMRN&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=NASDAQ%3AAMRN&s_ok=Get+Chart&period=8&drawmode=2&size=18&volume=1
You both clearly have a grasp of the situation, but the spike Feb 2015 supports FFS. A VW squeeze is possible.
BB
http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&s_symbol_select=NASDAQ%3AAMRN&ctl00%24sb3%24tbq1=&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=NASDAQ%3AAMRN&s_ok=Get+Chart&period=6&drawmode=2&size=18&volume=1
We could see a quick pop to $20 with spike in volume >10 million. For the chart to full correct we need 100 million shares traded day...like the post Oct 16th Ad Com.http://ih.advfn.com/p.php?pid=webchart&btn=s_ok&s_symbol_select=NASDAQ%3AAMRN&ctl00%24sb3%24tbq1=Get+Quote&as_values_IH=&ctl00%24sb3%24stb1=Search+iHub&symbol=NASDAQ%3AAMRN&s_ok=Get+Chart&period=8&drawmode=2&size=18&volume=1
If you not good at being yourself then maybe that's being yourself
Recent AMRN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
